Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Scolding

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Lancet (London, England)|July 30, 1994
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosisT Moreau, J Thorpe, D Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989
Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisoloneJ Kesselring, D H Miller, D G MacManus, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
CAMPATH-IH in multiple sclerosisT Moreau, A Coles, M Wing, et al.
European Journal of Neurology|September 18, 2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseasesI Elovaara, S Apostolski, P van Doorn, et al.
Neurology|July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohortM Cossburn, A A Pace, J Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2002
Intravenous immunoglobulin in neurological disease: a specialist reviewC M Wiles, P Brown, H Chapel, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Lancet (London, England)|July 30, 1994
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosisT Moreau, J Thorpe, D Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 1, 1989
Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisoloneJ Kesselring, D H Miller, D G MacManus, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 1, 1996
CAMPATH-IH in multiple sclerosisT Moreau, A Coles, M Wing, et al.
European Journal of Neurology|September 18, 2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseasesI Elovaara, S Apostolski, P van Doorn, et al.
Neurology|July 29, 2011
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohortM Cossburn, A A Pace, J Jones, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 23, 2002
Intravenous immunoglobulin in neurological disease: a specialist reviewC M Wiles, P Brown, H Chapel, et al.
Annals of the Rheumatic Diseases|August 21, 2010
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairsG K Bertsias, J P A Ioannidis, M Aringer, et al.
Pageof 4